Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

被引:9
|
作者
Warner, Ben [1 ]
Harris, Adam W. [1 ]
机构
[1] Tunbridge Wells Hosp Pembury, Dept Gastroenterol, Pembury, Kent, England
关键词
D O I
10.1053/j.gastro.2012.03.055
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:E42 / E42
页数:1
相关论文
共 50 条
  • [21] Etrolizumab in moderate-to-severe ulcerative colitis
    Armuzzi, Alessandro
    Felice, Carla
    [J]. LANCET, 2014, 384 (9940): : 285 - 286
  • [22] Cytomegalovirus colitis in patients with moderate-to-severe Ulcerative Colitis: diagnosis, clinical impact and treatment efficacy
    Melotti, L.
    Salice, M.
    Rinaldi, M.
    Dussias, N.
    Vanigli, N.
    Scaioli, E.
    Hrustemovic, H. Privitera
    Rizzello, F.
    Gionchetti, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I567 - I568
  • [23] Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
    Midha, Vandana
    Mahajan, Ramit
    Mehta, Varun
    Narang, Vikram
    Singh, Arshdeep
    Kaur, Kirandeep
    Sood, Ajit
    [J]. INTESTINAL RESEARCH, 2018, 16 (01) : 83 - 89
  • [24] Biologics for the treatment of moderate-to-severe ulcerative colitis in pediatric patients
    Albenberg, Lindsey G.
    Mamula, Petar
    Kelsen, Judith R.
    [J]. PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 51 - 58
  • [25] Is Long-Term Therapy With Thiopurines Effective for Maintaining Remission in Patients With Moderate-To-Severe Ulcerative Colitis?
    Jeon, Seong Ran
    Kim, Won Ho
    [J]. INTESTINAL RESEARCH, 2015, 13 (03) : 191 - 192
  • [26] Certolizumab Pegol Induces Clinical Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: An Open-Label Study
    Lee, Scott D.
    Clark-Snustad, Kindra
    Parrott, Susan
    Singla, Anand
    Osterman, Mark T.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S425 - S425
  • [27] Adalimumab Versus Infliximab in Inducing Mucosal Healing in Moderate-to-Severe Ulcerative Colitis: A Cost-Per-Remission Decision Analytic Study
    Park, K. T.
    Yokomizo, L.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S199 - S199
  • [28] CURRENT LANDSCAPE AND TREATMENTS USED IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS
    Siegel, C. A.
    Seigel, L.
    Verma, S.
    Sruti, I
    Mu, Q.
    Gupte, K.
    [J]. VALUE IN HEALTH, 2021, 24 : S99 - S99
  • [29] Clinical Remission Using the Patient-Reported Ulcerative Colitis Electronic Diary (UC e-Diary) in Adults With Moderate-to-Severe Ulcerative Colitis
    Tahir, Muna J.
    Shahraz, Saeid
    Kamble, Pravin
    Wang, Song
    Nagy, Peter
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S427 - S427
  • [30] Histological remission in patients with moderate-to-severe ulcerative colitis undergoing biological therapy: a single-centre experience
    Di Ruscio, M.
    Variola, A.
    Geccherle, A.
    Lunardi, G.
    Castelli, P.
    Zamboni, G.
    Riddell, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S441 - S442